Tornquist SJ, Van Saun RJ, Smith BB, et al. Hepatic lipidosis in llamas and alpacas: 31 cases (1991–1997). J Am Vet Med Assoc 1999; 214: 1368–1372.
Smith CC, Cebra CK. Effects of exenatide on plasma glucose and insulin concentrations in alpacas. J Vet Intern Med 2009; 23: 919–925.
Cebra CK. Hyperglycemia, hypernatremia, and hyperosmolarity in 6 neonatal llamas and alpacas. J Am Vet Med Assoc 2000; 217: 1701–1704.
Cebra CK, Tornquist SJ, McKane SA. Effects of hydrocortisone on substrates of energy metabolism in alpacas. Am J Vet Res 2002; 63: 1269–1274.
Cebra CK, Tornquist SJ. Assessment of the effects of epinephrine and insulin on plasma and serum biochemical variables in llamas and alpacas. Am J Vet Res 2004; 65: 1692–1696.
Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449–461.
Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359–1367.
Slomovitz BM, Lavery RF, Tortella BJ, et al. Validation of a handheld lactate device in determination of blood lactate in critically injured patients. Crit Care Med 1998; 26: 1523–1528.
Tennent-Brown BS, Wilkins PA, Lindborg S, et al. Assessment of a point-of-care lactate monitor in emergency admissions of adult horses to a referral hospital. J Vet Intern Med 2007; 21: 1090–1098.
Hollis AR, Dallap Schaer BL, Boston RC, et al. Comparison of the Accu-Chek Aviva point-of-care glucometer with blood gas and laboratory methods of analysis of glucose measurement in equine emergency patients. J Vet Intern Med 2008; 22: 1189–1195.
Louie RF, Tang Z, Sutton DV, et al. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med 2000; 124: 257–266.
Russell C, Palmer JE, Boston RC, et al. Agreement between point-of-care glucometry, blood gas and laboratory-based measurement of glucose in an equine neonatal intensive care unit. J Vet Emerg Crit Care 2007; 17: 236–242.
Gluco-quant Glucose/HK [package insert]. Indianapolis, Ind: Roche Diagnostics, 2006.
Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255–268.
Lin LI. Total deviation index for measuring individual agreement with applications in laboratory performance and bio-equivalence. Stat Med 2000; 19: 255–270.
Durando MM, Corley KT, Boston RC, et al. Cardiac output determination by use of lithium dilution during exercise in horses. Am J Vet Res 2008; 69: 1054–1060.
Bland JM, Altman DG. A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med 1990; 20: 337–340.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–310.
Bland JM, Altman DG. Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat 2007; 17: 571–582.
Gabbanelli V, Pantanetti S, Donati A, et al. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anestesiol 2005; 71: 717–725.
Bochicchio GV, Salzano L, Joshi M, et al. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am Surg 2005; 71: 171–174.
Hollis AR, Furr MO, Magdesian KG, et al. Blood glucose concentrations in critically ill neonatal foals. J Vet Intern Med 2008; 22: 1223–1227.
Hassel DM, Hill AE, Rorabeck RA. Association between hyperglycemia and survival in 228 horses with acute gastrointestinal disease. J Vet Intern Med 2009; 23: 1261–1265.
Hollis AR, Boston RC, Corley KT. Blood glucose in horses with acute abdominal disease. J Vet Intern Med 2007; 21: 1099–1103.
Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005; 33: 2778–2785.
Lin LI. A note on the concordance correlation coefficient. Biometrics 2000; 56: 324–325.
Ghys T, Goedhuys W, Spincemaille K, et al. Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters. Clin Chim Acta 2007; 386: 63–68.
Clarke WL, Cox D, Gonder-Frederick LA, et al. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987; 10: 622–628.
Arens S, Moons V, Meuleman P, et al. Evaluation of Glucocard Memory 2 and Accutrend sensor blood glucose meters. Clin Chem Lab Med 1998; 36: 47–52.
Lacara T, Domagtoy C, Lickliter D, et al. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care 2007; 16: 336–346.
Tang Z, Lee JH, Louie RF, et al. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 2000; 124: 1135–1140.
Kilpatrick ES, Rumley AG, Rumley CN. The effect of haemolysis on blood glucose meter measurement. Diabet Med 1995; 12: 341–343.
King JM, Eigenmann CA, Colagiuri S. Effect of ambient temperature and humidity on performance of blood glucose meters. Diabet Med 1995; 12: 337–340.
Advertisement
Objective—To compare the performance of 3 point-of-care glucose meters in adult and juvenile alpacas with that of a laboratory-based analyzer.
Design—Evaluation study.
Animals—35 adult alpacas and 21 juvenile alpacas.
Procedures—Whole blood samples obtained via jugular venipuncture were tested with all 3 point-of-care glucose meters; plasma samples were also tested with 1 of those meters. Glucose concentrations determined by use of the point-of-care meters were compared with results from the laboratory-based analyzer.
Results—Plasma glucose concentrations determined by use of the laboratory-based analyzer ranged from 36 to 693 mg/dL. Over the entire range of glucose concentrations tested, the Lin concordance correlation coefficient (agreement) was significant and excellent for all comparisons. Concordance decreased for 1 glucometer when testing whole blood samples over a narrower range of glucose concentrations (50 to 200 mg/dL). Bias was typically small (< 10 mg/dL) for 3 of the 4 comparisons but considerable for 1 meter with the use of whole blood. The limits of agreement were wide for all comparisons over the entire range of glucose concentrations tested but decreased to within acceptable limits when the narrower glucose range (50 to 200 mg/dL) was analyzed for 3 of the comparisons. For samples with a PCV < 25%, bias and the limits of agreement were greater for one of the meters tested.
Conclusions and Clinical Relevance—Discrepancies between point-of-care glucose meters and reference techniques can be considerable in alpacas, emphasizing the importance of assessing individual meter performance in a target population.
The authors thank David Carrel and Shalley Nottingham for technical assistance.
Supported by the American College of Veterinary Internal Medicine Foundation.